Diana Halim
Technik-/Wissenschafts-/F&E-Leiter bei KOLON TISSUEGENE, INC.
Profil
Diana M.
Halim is currently the Vice President-Clinical & Regulatory Affairs at Kolon TissueGene, Inc. She previously worked as the Director-Regulatory Affairs at AnGes, Inc. from 2008 to 2014, at Sucampo Pharmaceuticals LLC from 2014 to 2017, and at RRD International LLC from 2017 to 2019.
Ms. Halim has an undergraduate degree from George Washington University and a graduate degree from The Johns Hopkins University.
Aktive Positionen von Diana Halim
Unternehmen | Position | Beginn |
---|---|---|
KOLON TISSUEGENE, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Diana Halim
Unternehmen | Position | Ende |
---|---|---|
RRD International LLC
RRD International LLC Miscellaneous Commercial ServicesCommercial Services RRD International LLC develops biopharmaceutical products. The firm offers product development support to biotechnology, pharmaceutical and medical device companies. Its services include development, strategic planning, program management and research. The company was founded by Frank L. Hurley and Charles W. Finn in 2002 and is headquartered in Rockville, MD. | General Counsel | 01.12.2019 |
SUCAMPO PHARMACEUTICALS, INC. | General Counsel | 01.09.2017 |
ANGES, INC. | General Counsel | 01.09.2014 |
Ausbildung von Diana Halim
George Washington University | Undergraduate Degree |
The Johns Hopkins University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
KOLON TISSUEGENE, INC. | Health Technology |
ANGES, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
RRD International LLC
RRD International LLC Miscellaneous Commercial ServicesCommercial Services RRD International LLC develops biopharmaceutical products. The firm offers product development support to biotechnology, pharmaceutical and medical device companies. Its services include development, strategic planning, program management and research. The company was founded by Frank L. Hurley and Charles W. Finn in 2002 and is headquartered in Rockville, MD. | Commercial Services |
Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |